Google
BNBX 株価分析 — Applied Dna Sciences, Inc. (Financial Services >> Asset Management)
BNBX に関するよくある質問
BNBXのROE（自己資本利益率）は？
Applied Dna Sciences, Inc.のROEは-275.69%です。
BNBXの配当利回りは？
Applied Dna Sciences, Inc.の配当利回りは0.00%です。
BNBXの品質スコア（Quality Score）は？
当社のAIはBNBXの総合財務品質を100点中15点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
BNBXは今が買い時ですか？
当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
BNBXはどのセクターに属しますか？
Applied Dna Sciences, Inc.はFinancial Services >> Asset Managementセクターに分類されます（NASDAQ市場）
BNBX AI Analysis Summary
Our AI summary for BNBX: Applied Dna Sciences, Inc. (NASDAQ), Financial Services >> Asset Management sector. The stock currently trades at a P/E of 0.00, ROE of -275.69%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.11
Price
-0.00
(-1.87%)
Day Change
|
|
|---|
BNBX, ファンダメンタルスコアはnot good ( ファンダメンタル = 15) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
平均ROAが低い
平均ROAが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.11 |
| PBV / Sector |
0.07 / 1.67
GREAT
|
| Earning Per Share | -4.79 |
| PE / Sector |
N/A / 13.89
|
| PEG or PE/Growth / Sector |
N/A / 0.03
|
| Average 1M Daily Value |
0.05 M
GREAT
|
| Average 1W Daily Value |
1151.693620000000
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-06 07:59:43 |
| Symbol | BNBX |
| Name | APPLIED DNA SCIENCES, INC. |
| Sector | Financial Services >> Asset Management |
| Market | NASDAQ |
| Listed Shares | 7.20 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 0.79 / 7,445.49 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 50 Health Sciences Drive, Stony Brook, NY, United States, 11790
Phone: 631 240 8800
Website: https://www.bnbx.io
Description: BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
ME vs SECTOR Financial Services >> Asset Management
Click a bubble to view stock details · Bubble size represents market capitalization share
